The Oncologist's Guide to Synoptic Reporting: A Primer - FullText - Oncology 2020, Vol. 98, No. 6 - Karger Publishers
Improving tumor budding reporting in colorectal cancer: a Delphi consensus study | SpringerLink
Pathology Outlines - Features to report
Carcinoma of the ovary: FIGO* nomenclature | Download Table
MPH Colon Practicum : Breeze Training Transcript: Dec 4 06
2018 Updates for Neoplasms of the Appendix, Colon, Rectum and GI NETs
COLORECTAL CANCER STRUCTURED REPORTING PROTOCOL (4th Edition 2020)
Performance of a web-based method for generating synoptic reports Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA - J Pathol Inform
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group - The Lancet
Tumor budding assessment in CRC: why and how - CAP TODAY
Colon and Rectum
Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect
Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology
PDF) Protocol for the Examination of Specimens From Patients With Gastrointestinal Stromal Tumor
Journal of Pathology and Translational Medicine
Colon and Rectum
Current management of colorectal liver metastases | Colorectal Cancer
Performance of a web-based method for generating synoptic reports Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA - J Pathol Inform
CAP Cancer Protocol Colon NET
Fillable Online CAP Cancer Protocol Colon NET Fax Email Print - pdfFiller
CAP Cancer Protocol Colon
Definition of Synoptic Reporting The CAP has developed this list of
Colon and Rectum, Esophagus, Stomach, Anus, Pancreas Treatment Effect Codes
Colon & Rectum (neoplastic) | Gross Pathology Manual
Complete Pathology Reports: CAP Cancer Protocol for Colon and Rectum - Softworks Group
Fillable Online CAP Cancer Protocol Colon Fax Email Print - pdfFiller
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
